(Q35856905)

10 August 2017

1 reference

title

Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein (English)

1 reference

10 August 2017

1 reference

Daniel J Rader

1

1 reference

10 August 2017

1 September 2004

1 reference

Current Atherosclerosis Reports

10 August 2017

1 reference

10 August 2017

6

1 reference

10 August 2017

398-405

1 reference

10 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-004-0052-3

10 August 2017

0 references

cites work

New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-004-0052-3

Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-004-0052-3

Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-004-0052-3

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

21 January 2018

1 reference

12 December 2020

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

1 reference

12 December 2020

High-density lipoprotein--the clinical implications of recent studies

1 reference

12 December 2020

Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects

1 reference

12 December 2020

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

1 reference

12 December 2020

Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein

1 reference

12 December 2020

High-density lipoproteins as an emerging therapeutic target for atherosclerosis

1 reference

12 December 2020

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

1 reference

12 December 2020

Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits

1 reference

12 December 2020

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

1 reference

12 December 2020

Regulation and mechanisms of macrophage cholesterol efflux

1 reference

12 December 2020

Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein

1 reference

12 December 2020

Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction

1 reference

12 December 2020

Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans

1 reference

12 December 2020

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

1 reference

12 December 2020

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

1 reference

12 December 2020

Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study

1 reference

12 December 2020

High-density lipoprotein and the dynamics of atherosclerotic lesions

1 reference

12 December 2020

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

1 reference

12 December 2020

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency

1 reference

12 December 2020

Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene

1 reference

12 December 2020

Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene

1 reference

12 December 2020

Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population

1 reference

12 December 2020

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction

1 reference

12 December 2020

A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein Deficiency

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II.

1 reference

12 December 2020

Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate

1 reference

12 December 2020

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

1 reference

12 December 2020

Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease

1 reference

12 December 2020

Remodelling of high density lipoproteins by plasma factors

1 reference

12 December 2020

Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Polymorphisms in the CETP gene and association with CETP mass and HDL levels

1 reference

12 December 2020

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

1 reference

12 December 2020

Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia

1 reference

12 December 2020

The hepatic uptake of rat high-density lipoprotein cholesteryl ester is delayed after treatment with cholesteryl ester transfer protein

1 reference

12 December 2020

Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase

1 reference

12 December 2020

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

1 reference

12 December 2020

Genetic influences on lipid metabolism trait variability within the Stanislas Cohort

1 reference

12 December 2020

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

1 reference

12 December 2020

Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency

1 reference

12 December 2020

Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins

1 reference

12 December 2020

Unique lipoprotein phenotype and genotype associated with exceptional longevity

1 reference

12 December 2020

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial

1 reference

12 December 2020

Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency

1 reference

12 December 2020

The safety and immunogenicity of a CETP vaccine in healthy adults

1 reference

12 December 2020

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

1 reference

12 December 2020

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study

1 reference

12 December 2020

10.1007/S11883-004-0052-3

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15296707